Menyhárt O et al: Demographic shift disproportionately increases cancer burden in an aging nation – current and expected incidence and mortality in Hungary up to 2030, Clinical Epidemiology (2018)

Moll HP, Győrffy B, Casanova E et al. Afatinib restrains K-RAS-driven lung tumorigenesis. Science Translational Medicine (2018)

Ősz Á et al: A snapshot of 3649 Web-based services published between 1994 and 2017 shows a decrease in availability after 2 years. Briefings in Bioinformatics (2018)

Pongor L et al: Cell dispersal influences tumor heterogeneity and introduces a bias in NGS data interpretation, Scientific Reports (2017)

Menyhárt O et al: DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer, Oncotarget (2017)

Nagy Á et al.: KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer, International Journal of Cancer (2017)

Menyhárt O et al: Guidelines for the selection of functional assays to evaluate the hallmarks of cancer, BBA Reviews on Cancer (2016)

Sztupinszki Zs et al.: Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models, Scientific Reports (2016)

Lánczky A et al. : miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2,178 breast cancer patients, Breast Cancer Res Treat (2016)

Munkácsy Gy, Sztupinszki Zs et al: Validation of RNAi silencing efficiency using gene array data shows 18.5% failure rate across 429 independent experiments, Molecular Therapy — Nucleic Acids (2016)